河北医科大学学报

• 论著 • 上一篇    下一篇

孢曲松钠致胆囊结石1 027例文献分析#br#

  

  1. 1.河北省人民医院普外三科,河北 石家庄 050051;2.河北省人民医院普外一科,河北 石家庄 050051
  • 出版日期:2018-03-25 发布日期:2018-03-27
  • 作者简介:王春城(1976-),男,河北保定人,河北省人民医院主治医师,医学硕士,从事肝胆外科疾病诊治研究。
  • 基金资助:
    河北省医学科学研究重点课题(20160076)

Analysis of 1 027 cases of gallstones caused by ceftriaxone sodium

  1. 1.Third Department of General Surgery, Hebei General Hospital, Shijiazhuang 050051,China;
    2.First Department of General Surgery, Hebei General Hospital, Shijiazhuang 050051, China
  • Online:2018-03-25 Published:2018-03-27

摘要: [摘要]〓
〖HTH〗目的〖HTSS〗〖KG*2〗分析头孢曲松钠致胆囊结石的相关因素,为指导临床合理使用头孢曲松钠提供参考和证据。
〖HTH〗方法〖HTSS〗〖KG*2〗通过文献检索全面收集国内于1990年1月—2015年8月发表的头孢曲松钠导致胆囊结石不良反应报道,剔除不符合要求的文献,进行统计和分析。
〖HTH〗结果〖HTSS〗〖KG*2〗共检索到文献40篇,报道头孢曲松钠引起胆囊结石共计1 027例,通过超声或CT检查可确诊胆囊结石。其中男性比例多于女性,年龄<14岁患者164例;剂量过高是导致胆囊结石发病的主要因素,特别是超说明书剂量给药时,导致胆囊结石不良反应的比例随之升高;胆囊结石发生多在给药后15 d之内,尤其是连续给药3~7 d发生率相对较高;在不同形态的胆囊结石中,454例表现为泥沙型。停药后未经特殊治疗的胆囊结石多数在8~14 d内自行消失。
〖HTH〗结论〖HTSS〗〖KG*2〗临床过量使用头孢曲松钠可致胆囊假性结石的发生,应引起临床医师重视,应密切观察用药时患者的临床表现,一旦发现胆囊假性结石,应立即停用头孢曲松钠,改用其他方法处理。

关键词: 胆囊结石病, 头孢曲松钠, 药物毒性

Abstract: [Abstract] Objective〖HTSS〗〓To investigate the characteristics and associated factors of the adverse reactions of gallstones caused by ceftriaxone sodium so as to provide references and evidences for clinical rational use of ceftriaxone sodium.
〖HTH〗〖WTHZ〗Methods〖HTSS〗〓The adverse reactions of cholecystolithiasis caused by ceftriaxone sodium reported in domestic journal from January 1990 to August 2015 were analyzed statistically.
〖HTH〗〖WTHZ〗Results〖HTSS〗〓A total of 40 publications were eligible for this  analysis, and 1 027 ceftriaxone sodiuminduced cholecystolithiasis cases were collected,which can be diagnosed gallstones by ultrasound or CT examination. The adverse reactions were often seen in males than in females and partically seen in pediatric patients (164 cases), which should be given highly attention. Overdose was a major factor leading to the onset of gallstones, especially when doses exceed the specification, the proportion of adverse reactions will be increased. Gallstones will occur within 15 days after administration of ceftriaxone sodium, especially the incidence was relatively higher when continuous administration for 3-7 d. In different forms of gallstones, 454 patients showed sediment types. After stopping administrating, gallstones will disappear within 8-14 d without special treatment.
〖HTH〗〖WTHZ〗Conclusion〖HTSS〗〓Great attention should be paid to ceftriaxone sodiuminduced cholecystolithiasis. The clinical manifestation of the patients should be closely observed. Once the pseudostone of the gallbladder is found, ceftriaxone sodium should be discontinued immediately and then treated with other methods.

Key words: cholecystolithiasis, ceftriaxone, drug toxicity